skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 76  for All Library Resources

Results 1 2 3 4 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Perceived confidence of the local governments in controlling the COVID‐19 pandemic
Material Type:
Article
Add to My Research

Perceived confidence of the local governments in controlling the COVID‐19 pandemic

The Kaohsiung journal of medical sciences, 2020-09, Vol.36 (9), p.763-764 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1607-551X ;EISSN: 2410-8650 ;DOI: 10.1002/kjm2.12276 ;PMID: 32761728

Full text available

2
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis
Material Type:
Article
Add to My Research

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis

Cancer communications (London, England), 2019-12, Vol.39 (1), p.81-81, Article 81 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0424-2 ;PMID: 31796105

Full text available

3
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study
Material Type:
Article
Add to My Research

A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study

Cancer communications (London, England), 2019-11, Vol.39 (1), p.80-80, Article 80 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0426-0 ;PMID: 31775884

Full text available

4
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Material Type:
Article
Add to My Research

Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.76-76, Article 76 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0425-1 ;PMID: 31753020

Full text available

5
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Material Type:
Article
Add to My Research

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.78-78, Article 78 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0423-3 ;PMID: 31753015

Full text available

6
Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
Material Type:
Article
Add to My Research

Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study

Cancer communications (London, England), 2019-10, Vol.39 (1), p.1-4 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0405-5 ;PMID: 31601263

Full text available

7
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
Material Type:
Article
Add to My Research

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy

Cancer communications (London, England), 2019-10, Vol.39 (1), p.1-11 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0404-6 ;PMID: 31601270

Full text available

8
Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single‐center experience
Material Type:
Article
Add to My Research

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single‐center experience

Cancer communications (London, England), 2019-09, Vol.39 (1), p.1-6 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0395-3 ;PMID: 31558165

Full text available

9
Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis
Material Type:
Article
Add to My Research

Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis

Cancer communications (London, England), 2019-09, Vol.39 (1), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0394-4 ;PMID: 31519217

Full text available

10
Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases
Material Type:
Article
Add to My Research

Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases

Cancer communications (London, England), 2019-08, Vol.39 (1), p.1-4 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0392-6 ;PMID: 31443740

Full text available

11
Clinical outcomes of angiosarcoma: a single institution experience
Material Type:
Article
Add to My Research

Clinical outcomes of angiosarcoma: a single institution experience

Cancer communications (London, England), 2019-08, Vol.39 (1), p.1-4 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0389-1 ;PMID: 31387642

Full text available

12
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
Material Type:
Article
Add to My Research

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0384-6 ;PMID: 31234927

Full text available

13
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
Material Type:
Article
Add to My Research

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0383-7 ;PMID: 31221221

Full text available

14
A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes
Material Type:
Article
Add to My Research

A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-11 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0370-z ;PMID: 31182160

Full text available

15
Modelling the probability of erroneous negative lymph node staging in patients with colon cancer
Material Type:
Article
Add to My Research

Modelling the probability of erroneous negative lymph node staging in patients with colon cancer

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0377-5 ;PMID: 31171042

Full text available

16
CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial
Material Type:
Article
Add to My Research

CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-13 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0374-8 ;PMID: 31126331

Full text available

17
Is cancer‐related death associated with circadian rhythm?
Material Type:
Article
Add to My Research

Is cancer‐related death associated with circadian rhythm?

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-5 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0373-9 ;PMID: 31088540

Full text available

18
The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer
Material Type:
Article
Add to My Research

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-8 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0367-7 ;PMID: 31068222

Full text available

19
National trend of gastric cancer mortality in China (2003–2015): a population‐based study
Material Type:
Article
Add to My Research

National trend of gastric cancer mortality in China (2003–2015): a population‐based study

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-5 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0372-x ;PMID: 31046840

Full text available

20
An improved ileal conduit surgery for bladder cancer with fewer complications
Material Type:
Article
Add to My Research

An improved ileal conduit surgery for bladder cancer with fewer complications

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0366-8 ;PMID: 30999948

Full text available

Results 1 - 20 of 76  for All Library Resources

Results 1 2 3 4 next page

Searching Remote Databases, Please Wait